LEN vs MASI · rev $34.19B vs rev $2.09B
LEN (LEN) versus Masimo Corporation (MASI) — a side-by-side from cached financials, not a winner call.
LEN (LEN) common stock.
Masimo Corporation (MASI) is a medical devices company listed on US.
Latest reported LEN revenue for 2025-11-30 was $34.19B. Net income was $2.08B. Revenue was down 3.5% from 2024-11-30 to 2025-11-30. LEN currently screens at market cap $0.
Latest reported MASI revenue for 2024-12-28 was $2.09B. Net income was -$304.9M. Revenue was up 2.3% from 2023-12-30 to 2024-12-28. MASI currently screens at market cap $9.02B.
LEN currently screens at market cap $0. MASI currently screens at market cap $9.02B.
Not investment advice. Open the LEN and MASI stock pages for the full models.
Not investment advice.